Target intelligence / Profile preview

Neurotrophic factor receptor (No single abbreviation; common ones include TrkA, TrkB, TrkC, and p75NTR)

Target
No single abbreviation; common ones include TrkA, TrkB, TrkC, and p75NTR
Molecular classification
Receptor tyrosine kinases ("Tropomyosin-related kinase"/Trk family), Tumor necrosis factor superfamily member ("p75 neurotrophin receptor")
01

Overview

Neurotrophic factor receptors are a group of cell surface proteins that mediate the actions of neurotrophic factors—peptides essential for neuron survival, development, function, and plasticity. The best-characterized members are the tropomyosin-related kinases—TrkA/NTRK1 binds nerve growth factor (NGF), TrkB/NTRK2 binds brain-derived neurotrophic factor (BDNF) and NT4/5, while TrkC/NTRK3 binds NT3—and the low-affinity p75 neurotrophin receptor which can bind all classical neurotrophins but mediates distinct cellular responses including apoptosis under certain conditions. These receptors play critical roles during development by regulating neuronal number through survival/death decisions and continue into adulthood where they modulate synaptic function. Aberrant activation via mutation/fusion events drives tumorigenesis in some cancers; conversely loss-of-function contributes to degeneration seen in diseases like Alzheimer's disease. Both small molecule inhibitors targeting oncogenic fusion proteins and protein-based therapies aiming at neural repair/regeneration have been developed against this target class.

Other names
Neurotrophin receptorsNTRK1/2/3p75NTRLow-affinity nerve growth factor receptor (for p75NTR)
02

Mechanism of action

Drugs may act as antagonists/inhibitors of tyrosine kinase activity to block oncogenic signaling in tumors with NTRK gene fusions; some experimental agents act as agonists to promote neuronal survival in degenerative diseases by mimicking endogenous ligands like NGF or BDNF

03

Biological functions

Signal transductionNeuronal survivalNeuronal differentiationSynaptic plasticityCell proliferation or apoptosis depending on context
04

Disease associations

Neurodegenerative diseaseCancer/tumorigenesisPsychiatric disorders such as depression or schizophrenia
05

Safety considerations

Notable safety concerns include off-target effects due to widespread expression of these receptors throughout the nervous system and other tissues.Potential side effects from inhibition include neurologic symptoms such as paresthesia or cognitive changes; agonist therapies may risk aberrant cell growth or pain syndromes due to excessive trophic signaling
06

Interacting drugs

Larotrectinib

2 more in the full profile.

07

Biomarkers

Detection of NTRK gene fusions is used for patient selection in certain cancers treated with TRK inhibitors.Expression levels of BDNF/NGF can be monitored for efficacy/safety in neurological indications.

Beyond the preview

Go deeper on Neurotrophic factor receptor (No single abbreviation; common ones include TrkA, TrkB, TrkC, and p75NTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurotrophic factor receptor (No single abbreviation; common ones include TrkA, TrkB, TrkC, and p75NTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call